Professional
Added to YB: 2025-10-06
Pitch date: 2025-10-01
PHX.AX [neutral]
Pharmx Technologies Limited
-36.36%
current return
Author Info
No bio for this author
Company Info
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand.
Market Cap
AUD 58.0M
Pitch Price
AUD 0.13
Price Target
0.26 (+210%)
Dividend
N/A
EV/EBITDA
-37.73
P/E
-29.54
EV/Sales
7.34
Sector
Software
Category
growth
Infuse Partners Portfolio Holding: PharmX Technologies Limited
PHX.AX (holding update): Deep moat vs larger competitor FredIT who failed to compete. $1B non-drug products flow through systems - 5% take-rate = $50M high-margin revenue. Mgmt targets half that in 3-4yrs. Even with 50% multiple compression, stock could double. Risk: 10x sales, 10% growth, breakeven profits.
Read full article (2 min)